Residential Opioid Addiction Treatment in Georgia

West Georgia Wellness Center provides residential opioid addiction treatment in Hiram, Georgia for adults 18 and older. We treat opioid use disorder (OUD) involving any opioid substance — prescription opioids, fentanyl, heroin, morphine, oxycodone, hydrocodone, tramadol, and others — through a comprehensive program that includes medically supervised detox, medication-assisted treatment (MAT), evidence-based behavioral therapy, and integrated dual diagnosis care for co-occurring mental health conditions.

Opioid use disorder has become the most deadly addiction in American history, driven by the current fentanyl-contaminated drug supply. Effective treatment — particularly medication-assisted treatment — has never been more important, and it has never been more accessible. We are 30 minutes northwest of Atlanta and serve clients from throughout Georgia and the Southeast, with transportation assistance available for clients who need it.

Understanding the Opioid Class: What “Opioids” Includes

Opioids are a class of substances that bind to opioid receptors in the brain, spinal cord, and peripheral tissues, producing pain relief, euphoria, and sedation.

The opioid class includes a wide range of substances:

• Natural opiates — derived directly from the opium poppy plant: morphine and codeine
• Semi-synthetic opioids — chemically derived from natural opiates: heroin (from morphine), oxycodone (OxyContin, Percocet), hydrocodone (Vicodin, Norco), hydromorphone (Dilaudid), oxymorphone (Opana), buprenorphine
• Fully synthetic opioids — no plant-based precursors: fentanyl, methadone, tramadol

All opioids share the same fundamental mechanism of action — mu-opioid receptor activation — and all carry the potential for physical dependence and addiction with regular use. The specific clinical considerations differ by substance (half-life, onset of action, withdrawal timeline, overdose risk), but the treatment framework for OUD is the same regardless of which opioid is involved.

How the Opioid Epidemic Developed — Three Waves That Define Today’s Clinical Reality

Understanding the epidemic’s history helps explain why opioid use disorder presents the way it does today — and why the current clinical situation is uniquely urgent.

Wave 1 — Prescription opioids (1990s through approximately 2010): The epidemic began with aggressive marketing of extended-release opioids — particularly OxyContin — to physicians, with claims that addiction was rare when opioids were used for legitimate pain. Prescriptions increased dramatically. Prescription opioid use disorder became widespread. Many people who developed OUD from prescribed medications did not think of themselves as “addicts” — they had taken a medication their doctor prescribed, and now could not stop.

Wave 2 — Heroin (approximately 2010 through 2013): As prescription opioid regulations tightened and pill mills were shut down, many people with prescription OUD found their supply cut off. Heroin was cheaper, more available, and produced the same receptor effects. Heroin use increased dramatically among populations that had never historically been associated with heroin — suburban, middle-class, and rural white Americans who had begun with prescription opioids.

Wave 3 — Illicitly manufactured fentanyl (2013 through the present): The introduction of illicitly manufactured fentanyl (IMF) into the drug supply changed everything. IMF is 50 to 100 times more potent than morphine, produced without quality controls, and by 2020 had largely displaced heroin in most US markets. Overdose deaths increased sharply and have remained at historically unprecedented levels. Fentanyl is now found not only in the opioid supply but in cocaine, ecstasy, and counterfeit pills sold as prescription opioids or benzodiazepines.

The clinical implication: most people seeking treatment for opioid use disorder today have been using fentanyl, whether they know it or not. Treatment approaches — particularly buprenorphine induction protocols — need to account for fentanyl’s specific pharmacology. See our dedicated fentanyl treatment page for more on this.

What Opioid Withdrawal Looks Like — and Why It Drives Continued Use

Opioid withdrawal is not typically life-threatening in healthy adults — unlike alcohol or benzodiazepine withdrawal. But it is one of the most powerful drivers of continued use, and understanding why it is so difficult to endure without medical support helps explain why so many people struggle to stop on their own even when they genuinely want to.

Withdrawal timelines vary significantly by substance:

• Short-acting opioids (heroin, oxycodone, hydrocodone) — symptoms begin 8 to 24 hours after last use, peak at 36 to 72 hours, mostly resolve within 5 to 7 days
• Fentanyl — shorter plasma half-life but significant fat tissue accumulation creates a complex withdrawal picture; onset within 2 to 12 hours of last use, duration variable based on use pattern
• Long-acting opioids (methadone, extended-release morphine) — onset delayed to 24 to 48 hours, peak at 5 to 7 days, can extend significantly beyond 2 weeks
• Tramadol — produces both opioid and serotonergic withdrawal; unique atypical symptoms alongside classical opioid withdrawal; see our tramadol page for details

Physical withdrawal symptoms include intense cravings, severe muscle aches and cramps (often described as a flu that is ten times worse than any flu), profuse sweating and goosebumps (hence the phrase “cold turkey,” from the appearance of the skin), nausea, vomiting, and diarrhea, insomnia that can be profound and persistent, and severe anxiety and agitation. The psychological experience — particularly the total absence of pleasure and the overwhelming craving — is what most people find impossible to endure without support.

At West Georgia Wellness Center, opioid detox is supervised around the clock. Our physicians use FDA-approved withdrawal management protocols including buprenorphine for symptom management and MAT initiation, clonidine for autonomic symptoms, antiemetics, sleep aids, and supportive medications for comfort. Following detox, clients transition directly into our residential treatment program.

Medication-Assisted Treatment (MAT) for Opioid Use Disorder

MAT is the evidence-based gold standard for opioid use disorder treatment.

The research evidence is clear, consistent, and compelling across decades and thousands of studies:

• MAT reduces illicit opioid use by 50 to 70 percent or more compared to behavioral treatment alone
• MAT reduces overdose mortality by up to 50 percent — one of the most dramatic mortality-reduction effects of any intervention in addiction medicine
• MAT reduces criminal activity and improves employment and social functioning
• MAT improves treatment retention significantly compared to non-medication approaches

Despite this evidence, MAT remains underutilized — partly because of persistent cultural stigma about “trading one drug for another” (a mischaracterization of what MAT does clinically) and partly because access has historically been limited. West Georgia Wellness Center integrates MAT as a core component of opioid use disorder treatment for appropriate clients.

Buprenorphine (Suboxone, Sublocade) is a partial opioid agonist — it activates opioid receptors enough to eliminate withdrawal and cravings, but with a ceiling effect that prevents the respiratory depression that causes opioid overdose. Buprenorphine also has a built-in “blocking” effect: when taken at therapeutic doses, it occupies opioid receptors in a way that significantly reduces the effect of additional opioids. For most clients with OUD, buprenorphine initiated during residential treatment and continued with a community prescriber after discharge represents the strongest available clinical approach. Sublocade (monthly injectable buprenorphine) eliminates the daily medication management challenge.

Naltrexone (Vivitrol) is an opioid antagonist — it blocks opioid receptors completely, preventing any opioid effect and eliminating craving. Unlike buprenorphine, naltrexone requires complete detoxification before initiation (it will precipitate severe withdrawal if given before full detox is complete). The monthly injectable Vivitrol form has significant advantages over daily oral naltrexone for adherence. Naltrexone is an appropriate option for clients who are fully detoxed and strongly prefer a non-opioid medication.

Our physicians review both options with every client who has OUD and make evidence-based recommendations based on clinical history, fentanyl exposure (which affects buprenorphine induction protocols), preference, and suitability.

Opioid Use Disorder and Co-Occurring Mental Health Conditions

Depression, PTSD, anxiety, and chronic pain co-occur with opioid use disorder at very high rates. For many people, opioid use began as self-medication — an attempt to manage untreated psychological pain, physical pain from injury or chronic illness, or trauma symptoms that were not being adequately addressed. Opioids are extraordinarily effective at relieving both physical and psychological pain in the short term, which makes them particularly prone to compulsive use in people with significant underlying pain of either type.

Over time, opioid use worsens the underlying conditions it was used to manage: opioid-induced depression deepens existing depression, opioid-related sleep disruption worsens anxiety, and the progressive consequences of addiction create new trauma and loss that add to the existing burden.

West Georgia Wellness Center treats opioid use disorder and co-occurring mental health conditions simultaneously through our integrated dual diagnosis program. Co-occurring conditions we commonly treat alongside OUD include major depression, PTSD and complex trauma, anxiety disorders, and bipolar disorder.

The Specific Danger of the Current Drug Supply

Anyone treating opioid use disorder in 2026 must account for the fentanyl reality. The overwhelming majority of substances sold as heroin, and a substantial proportion of counterfeit prescription pills, now contain illicitly manufactured fentanyl.

This has several critical clinical implications:

• Overdose risk is dramatically higher than historical data from the pre-fentanyl era would suggest
• Tolerance drops quickly after any abstinence, but the potency of the drug supply does not — the transition back out of residential treatment is a period of elevated overdose risk
• Buprenorphine induction for fentanyl-dependent clients requires modified protocols (low-dose or microdosing induction) to avoid precipitated withdrawal
• Naloxone (Narcan) training and provision are essential components of discharge planning for all clients with OUD

Discharge from residential treatment for OUD includes: confirmed prescriber for ongoing MAT, confirmed outpatient therapist, psychiatric care continuation, a written relapse prevention plan that specifically addresses the overdose risk during the post-discharge period, a naloxone kit with training for both the client and any family members, and PHP or IOP referral when clinically appropriate.

For Specific Opioid Substances

For clinical information on specific opioid substances, see our dedicated treatment pages:

• fentanyl addiction treatment
• heroin addiction treatment
• morphine addiction treatment
• opiate addiction treatment
• tramadol addiction treatment.

Insurance Coverage for Opioid Addiction Treatment

Opioid use disorder treatment — including medical detox, residential treatment, and MAT — is covered under most major commercial insurance plans. Federal mental health parity law requires coverage at the same level as physical health care. West Georgia Wellness Center accepts Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, Humana, Tricare, UMR, Magellan, and most other major commercial plans. We verify benefits at no cost, confirm your specific coverage, and explain your costs before you make any decisions about admission.

Frequently Asked Questions — Opioid Addiction Treatment

What is opioid use disorder?

The clinical diagnosis for compulsive opioid use causing significant impairment — not simply physical dependence. Criteria include failed attempts to stop, continued use despite consequences, tolerance, withdrawal, and spending excessive time obtaining or using opioids. OUD is a medical condition with effective, evidence-based treatments.

What is the difference between opioid physical dependence and OUD?

Physical dependence is an expected pharmacological consequence of regular opioid use — it means withdrawal occurs if the drug is stopped. OUD is the additional layer of compulsive, out-of-control use despite consequences. Many people have physical dependence without OUD (people using prescribed opioids appropriately for chronic pain). OUD always involves physical dependence plus the behavioral and psychological pattern of addiction.

What is MAT and why does it work?

Medication-assisted treatment uses FDA-approved medications — buprenorphine or naltrexone — alongside behavioral therapy to reduce cravings, prevent relapse, and support recovery. MAT reduces overdose mortality by up to 50 percent and reduces illicit opioid use by 50 to 70 percent compared to behavioral treatment alone. It is the gold standard of care for OUD.

How did the opioid epidemic develop?

Three waves: prescription opioid overprescribing in the 1990s → transition to heroin around 2010 → fentanyl contamination of the supply beginning around 2013. We are now in the most deadly phase, driven by illicitly manufactured fentanyl that has contaminated not just the heroin supply but pills, cocaine, and other drugs.

Can opioid use disorder be treated alongside mental health conditions?

Yes — and it must be. Depression, PTSD, and anxiety co-occur with OUD at very high rates. Treating only the addiction without addressing the mental health condition produces worse outcomes than integrated dual diagnosis treatment. West Georgia Wellness Center treats both simultaneously.